You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1388-ESGO Comparison of disease free interval among cervical cancer patients who underwent concurrent chemoradiation for 10 years at a single institution in Korea; What about cervical adenocarcinoma?

Article metrics

Article menu

Download PDFPDF

Cervical cancer
2022-RA-1388-ESGO Comparison of disease free interval among cervical cancer patients who underwent concurrent chemoradiation for 10 years at a single institution in Korea; What about cervical adenocarcinoma?
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

AbstractFullPdf
Oct 2022401
Nov 20222702
Dec 202246013
Jan 20231001
Feb 20231002
Mar 2023901
Apr 20231102
May 20231203
Jun 2023300
Jul 20231303
Aug 2023805
Sep 20231201
Oct 20231200
Nov 20231001
Dec 20232900
Jan 20241202
Feb 20241301
Mar 20241504
Apr 20241008
Total266050